Bone Marrow Eosinophilia Correlates with Progression Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Georgieva, Y. [1 ]
Michova, A. [1 ]
Ganeva, P. [2 ]
Petrov, Y. [2 ]
Madzharova, V. [1 ]
Spassov, B. [2 ]
Balatzenko, G. [3 ]
Arnaudov, G. [2 ]
Mihaylov, G. [2 ]
Guenova, M. [1 ]
机构：
[1] Natl Specialised Hosp Act Treatment Hematol Dis, Lab Hematopathol & Immunol, Sofia, Bulgaria
[2] Natl Specialised Hosp Act Treatment Hematol Dis, Hematol Clin, Sofia, Bulgaria
[3] Natl Specialised Hosp Act Treatment Hematol Dis, Lab Cytogenet & Mol Biol, Sofia, Bulgaria
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P620
引用
收藏
页码：S444 / S445
页数：2
相关论文
共 50 条
  • [1] BONE MARROW EOSINOPHILIA CORRELATES WITH TREATMENT OUTCOMES BOTH AFTER AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Georgieva, Y.
    Petrov, Y.
    Spassov, B.
    Balatzenko, G.
    Ganeva, P.
    Madzharova, V.
    Mihaylov, G.
    Arnaudov, G.
    Guenova, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 615 - 616
  • [2] Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
    Szyska, Martin
    Na, Il-Kang
    [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [3] Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kroeger, N.
    Zabelina, T.
    Berger, J.
    Duske, H.
    Klyuchnikov, E.
    Binder, T.
    Stuebig, T.
    Hilde-Brandt, Y.
    Atanackovic, D.
    Alchalby, H.
    Ayuk, F.
    Zander, A. R.
    Bacher, U.
    Eiermann, T.
    [J]. LEUKEMIA, 2011, 25 (10) : 1657 - 1661
  • [4] Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    N Kröger
    T Zabelina
    J Berger
    H Duske
    E Klyuchnikov
    T Binder
    T Stübig
    Y Hilde-brandt
    D Atanackovic
    H Alchalby
    F Ayuk
    A R Zander
    U Bacher
    T Eiermann
    [J]. Leukemia, 2011, 25 : 1657 - 1661
  • [5] Late Donor Bone Marrow Failure After Allogeneic Hematopoietic Stem Cell Transplantation
    Meunier, Mathieu
    Manez, Anne-Claire
    Xhaard, Alienor
    de Latour, Regis Peffault
    de Fontbrune, Flore Sicre
    Dhedin, Nathalie
    Socie, Gerard
    Robin, Marie
    [J]. TRANSPLANTATION, 2014, 97 (12) : E75 - E77
  • [6] Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
    Masouridi-Levrat, Stavroula
    Simonetta, Federico
    Chalandon, Yves
    [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [7] Risk Factors for Readmission after Allogeneic Hematopoietic Stem Cell Transplantation and Impact on Overall Survival
    Spring, Laura
    Li, Shuli
    Soiffer, Robert J.
    Antin, Joseph H.
    Alyea, Edwin P., III
    Glotzbecker, Brett
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 509 - 516
  • [8] Early Immune Recovery Predicts Overall and Disease-Free Survival After Allogeneic Hematopoietic Stem Cell Transplantation
    Goldberg, Jenna D.
    Zheng, Junting
    Barker, Juliet
    Boulad, Farid
    Castro-Malaspina, H. R.
    Hsu, Katharine C.
    Jakubowski, Ann
    Kernan, Nancy
    O'Reilly, Richard J.
    Papadopoulos, Esperanza
    Prockop, Susan
    Scaradavou, Andromachi
    van den Brink, Marcel
    Young, James
    Heller, Glenn
    Perales, Miguel-Angel
    [J]. BLOOD, 2009, 114 (22) : 875 - 876
  • [9] Eosinophilia during letermovir treatment after allogeneic hematopoietic stem cell transplantation
    Hiroki Hosoi
    Shogo Murata
    Toshiki Mushino
    Akinori Nishikawa
    Takashi Sonoki
    [J]. Annals of Hematology, 2020, 99 : 2453 - 2454
  • [10] Eosinophilia during letermovir treatment after allogeneic hematopoietic stem cell transplantation
    Hosoi, Hiroki
    Murata, Shogo
    Mushino, Toshiki
    Nishikawa, Akinori
    Sonoki, Takashi
    [J]. ANNALS OF HEMATOLOGY, 2020, 99 (10) : 2453 - 2454
12345